Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2013-12-18

Clinical Trial Update: Quality of Life in Patients Who Are Receiving Either Vinorelbine, Gemcitabine, and Docetaxel or Paclitaxel and Carboplatin for Advanced Non-Small Cell Lung Cancer

View source ↗

Summary

This clinical trial update discusses quality of life in patients with advanced non-small cell lung cancer treated with two chemotherapy regimens: vinorelbine, g…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gemzar (gemcitabine)
  • Navelbine (vinorelbine)
  • Paraplatin (Carboplatin)
  • Taxol (paclitaxel)
  • Taxotere (docetaxel)

Snippet

Sponsor: National Hospital Organization Kinki-chuo Chest Medical Center | Conditions: Lung Cancer | Status: UNKNOWN